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Objective	The	aim	of	this	research	was	the	development	and	validation	of	a	translational	model	for	the	evaluation	of	exercise	and	nutrient	stimulated	muscle	protein	synthesis	 (MPS).	To	achieve	 this	overall	aim,	three	primary	objectives	had	to	be	realised:	(i)	Development	of	an	in	vitro	skeletal	muscle	cell	bioassay	to	measure	muscle	growth	and	MPS;	(ii)	Development	of	an	ex	vivo	model	to	evaluate	the	humoral	 effect	 on	MPS	 in	 response	 to	 nutrient	 feeding	 and	 exercise;	 (iii)	 Use	 of	 a	 stable	 isotope	technique	to	evaluate	MPS	in	response	to	nutrient	feeding	and	exercise	in	vivo.	
Methods	To	develop	a	novel	in	vitro	skeletal	muscle	cell	bioassay	to	measure	muscle	growth	and	MPS,	C2C12	myoblasts	were	proliferated	and	subsequently	differentiated	to	myotubes	over	8	days	in	DMEM	(2%	HS).	Changes	in	cell	behavior	and	adhesion	properties	were	monitored	by	measuring	impedance	via	interdigitated	microelectrodes	using	the	xCELLigence	system.	MPS	was	measured	by	puromycin	incorporation	 using	 the	 SUnSET	 technique,	 intracellular	 signalling	measured	 by	western	 blot,	 and	myotube	thickness	by	microscopy.	To	demonstrate	the	capability	 to	monitor	nutrient	regulation	of	muscle	 growth,	media	was	 conditioned	with	 a	 known	potent	 regulator	 of	MPS	 (leucine)	 in	 a	 dose	response	experiment	(0.20	-	2.0	mM).	To	establish	the	ability	of	the	bioassay	to	measure	the	humoral	effect	of	MPS	in	response	to	feeding	and	exercise,	media	was	conditioned	by	ex	vivo	human	serum	from	fasted,	rested,	fed	(protein	and	isonitrogenous	non-essential	amino	acid	(NEAA)	control)	 	and	post-exercise	conditions.	To	evaluate	MPS	in	response	to	nutrient	feeding	and	exercise	in	vivo,	acute	MPS	(5	h)	was	assessed	by	measuring	stable	isotope	deuterium	oxide	(D2O)	incorporation	into	m.	vastus	lateralis	skeletal	muscle	following	consumption	of	either	a	Whey	Protein	(WP)	or	an	isonitrogenous	NEAA	control	combined	with	resistance	exercise	in	resistance	trained	males.	
Results	In	vitro	experiments	observed	a	dose-response	effect	with	a	32	%	increase	in	cell	index	and	a	27	%	increase	in	cell	thickness	after	2	h	in	the	presence	of	2.0	mM	leucine	when	compared	with	control	myotubes.	Ex	 vivo	 serum	 following	 ingestion	 of	 NEAA	 had	 no	 effect	 on	 protein	 signalling	 or	MPS	whereas	WP	fed	serum	significantly	increased	mTOR,	P70S6K	and	4E-BP1	phosphorylation	(p<0.01,	p<0.05)	compared	to	fasted	serum.	Furthermore,	the	effect	of	WP	fed	serum	on	protein	signalling	and	MPS	was	significantly	increased	(p<0.01,	p<0.05)	compared	to	NEAA	fed	serum.		Ex	vivo	human	serum	following	resistance	exercise	was	also	 increased	MPS	(29	%)	and	phosphorylation	of	mTOR	(6	%),	p70S6K	 (12	 %)	 and	 4EBP1	 (7	 %),	 compared	 with	 resting	 serum.	 These	 ex	 vivo/in	 vitro	 findings	translated	 to	 the	 in	 vivo	 model	 as	 myofibrillar	 fractional	 synthetic	 rates	 (myoFSR)	 (Basal	0.068±0.002%h-1	 vs.	 WP	 0.084±0.006	 %h-1,	 p=0.033)	 and	 absolute	 synthetic	 rates	 (ASR)	 (Basal	10.34±1.01	vs.	WP	13.18±0.71	g.day-1,	p=0.026)	were	increased	from	basal	levels	only	when	resistance	exercise	was	combined	with	WP	ingestion	and	not	the	NEAA	control	(NEAA	MPS	0.072±0.004%h-1,	NEAA	 ASR	 10.23±0.80	 g.day-1).		 Thus,	 ingestion	 of	 WP	 in	 combination	 with	 resistance	 training	augments	acute	MPS	responses	in	resistance	trained	young	men.	
Conclusions	We	have	developed	a	translational	model	of	muscle	protein	synthetic	bioactivity	using	in	
vitro,	ex	vivo	and	in	vivo	methodologies.	We	have	shown	that	we	can	impact	MPS	in	vitro	using	ex	vivo	human	 serum	 to	 condition	 media,	 that	 MPS	 in	 vitro	 is	 differentially	 regulated	 by	 ex	 vivo	 serum	containing	 bioactive	 WP	 compared	 to	 a	 non-bioactive	 NEAA	 control,	 and	 that	 this	 tranlates	 for	resistance	 exercise	 combined	with	WP	 in	humans	when	MyoFSR	 is	measured	using	 stable	 isotope	
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technology.		These	experiments	demonstrate	that	ex	vivo/in	vitro	experiments	translate	to	the	in	vivo	model	and	these	methods	can	be	used	to	inform	both	exercise	and	nutrient	human	interventions.			
